Logo image of CYRN

CYREN LTD (CYRN) Stock Fundamental Analysis

NASDAQ:CYRN - Nasdaq - IL0010832371 - Common Stock - Currency: USD

0.2182  -0.06 (-20.65%)

After market: 0.204 -0.01 (-6.51%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CYRN. CYRN was compared to 283 industry peers in the Software industry. Both the profitability and financial health of CYRN have multiple concerns. CYRN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CYRN has reported negative net income.
In the past year CYRN has reported a negative cash flow from operations.
CYRN Yearly Net Income VS EBIT VS OCF VS FCFCYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -5M -10M -15M -20M

1.2 Ratios

The profitability ratios for CYRN are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYRN Yearly ROA, ROE, ROICCYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -50 -100 -150

1.3 Margins

CYRN has a Gross Margin of 44.77%. This is in the lower half of the industry: CYRN underperforms 70.90% of its industry peers.
In the last couple of years the Gross Margin of CYRN has declined.
CYRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5%
GM growth 5Y-5.47%
CYRN Yearly Profit, Operating, Gross MarginsCYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

CYRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CYRN has been reduced compared to 1 year ago.
The debt/assets ratio for CYRN has been reduced compared to a year ago.
CYRN Yearly Shares OutstandingCYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
CYRN Yearly Total Debt VS Total AssetsCYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

CYRN has an Altman-Z score of -13.46. This is a bad value and indicates that CYRN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -13.46, CYRN is not doing good in the industry: 90.64% of the companies in the same industry are doing better.
A Debt/Equity ratio of 2.30 is on the high side and indicates that CYRN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.30, CYRN is doing worse than 81.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.3
Debt/FCF N/A
Altman-Z -13.46
ROIC/WACCN/A
WACC3.12%
CYRN Yearly LT Debt VS Equity VS FCFCYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.29 indicates that CYRN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.29, CYRN is doing worse than 65.22% of the companies in the same industry.
CYRN has a Quick Ratio of 1.29. This is a normal value and indicates that CYRN is financially healthy and should not expect problems in meeting its short term obligations.
CYRN has a Quick ratio of 1.29. This is in the lower half of the industry: CYRN underperforms 64.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
CYRN Yearly Current Assets VS Current LiabilitesCYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

CYRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.04%, which is quite impressive.
CYRN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.53%.
Measured over the past years, CYRN shows a small growth in Revenue. The Revenue has been growing by 0.13% on average per year.
EPS 1Y (TTM)23.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)-13.53%
Revenue growth 3Y-4.58%
Revenue growth 5Y0.13%
Sales Q2Q%3.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYRN Yearly Revenue VS EstimatesCYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
CYRN Yearly EPS VS EstimatesCYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CYRN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYRN Price Earnings VS Forward Price EarningsCYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYRN Per share dataCYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYREN LTD

NASDAQ:CYRN (3/2/2023, 8:00:01 PM)

After market: 0.204 -0.01 (-6.51%)

0.2182

-0.06 (-20.65%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-21 2023-02-21
Earnings (Next)05-15 2023-05-15
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners46.3%
Ins Owner Change0%
Market Cap1.75M
Analysts82.86
Price Target1.53 (601.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-1.57
OCFYN/A
SpS3.08
BVpS0.47
TBVpS-0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.77%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5%
GM growth 5Y-5.47%
F-Score3
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 2.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.66%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z -13.46
F-Score3
WACC3.12%
ROIC/WACCN/A
Cap/Depr(3y)23.38%
Cap/Depr(5y)32.05%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.53%
Revenue growth 3Y-4.58%
Revenue growth 5Y0.13%
Sales Q2Q%3.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.44%
OCF growth 3YN/A
OCF growth 5YN/A